Endoglin as a BMP9 co-receptor in vascular endothelial cells: prodomain displacement and TGFBRII recruitment

Endoglin (ENG) is a single-pass transmembrane protein highly expressed in vascular endothelial cells (ECs), where it plays fundamental roles in EC functions. ENG is implicated in several cardiovascular disorders including hereditary haemorrhagic telangiectasia, pulmonary arterial hypertension (PAH) and preeclampsia. However, molecular mechanisms underlying ENG function are not fully understood. Initially identified as a co-receptor for TGF-β signalling, ENG's extracellular domain was later found to only bind BMP9 and BMP10 with high affinity. The relationship between these two observations is unclear. Here, we provide evidence for two primary functions of co-receptor ENG. First, ENG efficiently displaces prodomains from BMP9 and BMP10, enabling effective capturing of both ligands from the circulation. Second, ENG binds to and recruits TGFBRII into the BMP9 signalling complex, thereby explaining ENG's involvement in both TGF-β and BMP9 pathways. We identify BMP9 target genes NOG and ADAMTSL2 as preferentially dependent on ENG and show that their transcript levels have strong positive correlation with ENG in human lung tissues; the expression levels of all three genes are significantly reduced in PAH. Our findings address an important gap in our understanding on ENG biology and provide crucial insight for therapeutic targeting these pathways in vascular diseases.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2025-12-31
DOI
https://doi.org/10.1038/s41467-025-67531-9
Primary Topic
Pulmonary Hypertension Research and Treatments
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Endoglin as a BMP9 co-receptor in vascular endothelial cells: prodomain displacement and TGFBRII recruitment

Jingxu Guo, Marie-José T Goumans, Helen M. Arthur, Adam J. Brownstein et al.
Nature Communications
Pulmonary Hypertension Research and Treatments
article

Endoglin as a BMP9 co-receptor in vascular endothelial cells: prodomain displacement and TGFBRII recruitment

Jingxu Guo, Marie-José T Goumans, Helen M. Arthur, Adam J. Brownstein, R. Jones, Midory Thorikay, E. Groeneveld, Xudong Yang, Martin R. Wilkins, Karolina Kostrzynska, Wei Li, Zhen Tong, Lu Long, Allan Lawrie, Evangelia Petsalaki, Christopher J. Rhodes, Eckart De Bie, Jason Hong, Ioannis Kamzolas, Mark R. Toshner, Antonio Vidal-Puig
article en

Abstract

Endoglin (ENG) is a single-pass transmembrane protein highly expressed in vascular endothelial cells (ECs), where it plays fundamental roles in EC functions. ENG is implicated in several cardiovascular disorders including hereditary haemorrhagic telangiectasia, pulmonary arterial hypertension (PAH) and preeclampsia. However, molecular mechanisms underlying ENG function are not fully understood. Initially identified as a co-receptor for TGF-β signalling, ENG's extracellular domain was later found to only bind BMP9 and BMP10 with high affinity. The relationship between these two observations is unclear. Here, we provide evidence for two primary functions of co-receptor ENG. First, ENG efficiently displaces prodomains from BMP9 and BMP10, enabling effective capturing of both ligands from the circulation. Second, ENG binds to and recruits TGFBRII into the BMP9 signalling complex, thereby explaining ENG's involvement in both TGF-β and BMP9 pathways. We identify BMP9 target genes NOG and ADAMTSL2 as preferentially dependent on ENG and show that their transcript levels have strong positive correlation with ENG in human lung tissues; the expression levels of all three genes are significantly reduced in PAH. Our findings address an important gap in our understanding on ENG biology and provide crucial insight for therapeutic targeting these pathways in vascular diseases.

Nature CommunicationsVol. 17(1)
European Bioinformatics Institute (GB), University of California, Los Angeles (US), Leiden University Medical Center (NL), Centre for Life (GB), Cambridge School (PT), Wellcome/MRC Institute of Metabolic Science (GB), MRC Epidemiology Unit (GB), Centro de Investigacion Principe Felipe (ES), Imperial College London (GB), Newcastle University (GB)
Bill and Melinda Gates Foundation, European Bioinformatics Institute, European Molecular Biology Laboratory, National Institute for Health and Care Research, British Heart Foundation, Department of Health and Social Care, Cambridge Trust, Gates Cambridge Trust, National Institutes of Health
Openalex Percentile: Top 27%
Pulmonary Hypertension Research and Treatments
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.